Myopia Management

Enter the child (or adult) profile, compare treatment trajectories, and get a reasoned, evidence-ranked plan — spectacles, contact lenses, atropine, ortho-k, red light and combinations.

Illustrative projection — clinical decision support only

The graph is a population-based projection to support the treatment conversation, calibrated to entered parameters. It is not a per-patient prediction, diagnosis or guarantee. Efficacy figures are population values from published trials (comparators and uncertainty bands shown) and require practitioner review. Atropine dosing and contraindications live in the Therapeutics module. No patient identifiers are entered or stored.

Clinical basis, model and references

The projection applies an age-banded population progression rate (Donovan 2012 / COMET anchors, tapering to a small residual adult term, with a ~1.4× East-Asian multiplier) and slows it by each treatment's published control percentage, shown as a band to reflect between-trial uncertainty. Ortho-k and RLRL are scored on axial length. The plan engine ranks brand-neutral categories by evidence and age suitability; products are listed as equal examples and never change the ordering. Model values and wording require practitioner review before being treated as settled.

Intra-app resources

Evidence base

Population reference values for a deterministic, explainable projection — not diagnosis. Sources reviewed 22 July 2026. Clinical wording, band values and product labels require practitioner review before wider release.

Products & brands available in Australia (21)

Myopia-control spectacle lenses

CR Labs MyoStock / MyoME — Australian-made defocus
Essilor Stellest — Stellest 2.0
Hoya MiYOSMART — clear · Sunbird polarised · Chameleon photochromic
Rodenstock MyCon 2
SightGlass DOT — Diffusion Optics Technology
Zeiss MyoCare / MyoCare S — C.A.R.E.

Myopia-control soft contact lenses

CooperVision Biofinity / Proclear multifocal — off-label
CooperVision MiSight 1 day — dual-focus, TGA-registered
J&J Acuvue Abiliti 1-Day — RingBoost — TGA ARTG 475505, launched AU 2025
Visioneering NaturalVue Multifocal 1 Day — EDOF

Orthokeratology

AU labs: Capricornia / Gelflex / BE Enterprises
CooperVision Paragon CRT
Euclid Emerald
Forge (Precision Technology) / EyeSpace-designed
Menicon Bloom Night

Low-dose atropine

compounded 0.01%
compounded 0.05%
EIKANCE 0.01% — Aspen — TGA-registered, ages 4–14
EIKANCE 0.05% — Aspen — TGA-registered June 2026

Repeated low-level red light

Eyerising Myopia Management Device — TGA-included, home use

Combination approaches

Ortho-k lens + EIKANCE atropine — 0.01–0.05%

OptoGuide is not an advertising platform. This is a clinical reference — a brand↔active-ingredient lookup and a list of options available in Australia — sorted alphabetically by type. OptoGuide’s recommendations are based on scientific evidence and clinical appropriateness; they cannot be bought, promoted, or reordered by sponsorship, and inclusion here is not endorsement. Always verify current registration, PBS status and suitability for your patient.

Help keep this reference accurate

Spotted a missing product, a registration or PBS change, or an error? Manufacturers, distributors and clinicians are all welcome to let us know so we can keep this list current. Listing is a neutral clinical reference — it does not affect OptoGuide’s recommendations, which are based on evidence and cannot be bought or reordered by sponsorship.

support@optoguide.com.au

Browse the full brand & product directory